Berks Oncology and Hematology Associates — West Reading, Pennsylvania

Berks Oncology and Hematology Associates is a clinical research site located in West Reading, Pennsylvania, United States 19611.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Berks Oncology and Hematology Associates has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Berks Oncology and Hematology Associates?

Berks Oncology and Hematology Associates has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Berks Oncology and Hematology Associates conducted?

Berks Oncology and Hematology Associates has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Berks Oncology and Hematology Associates accredited by Crixeo Health?

Berks Oncology and Hematology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Berks Oncology and Hematology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.